Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

PHSYX vs PRHSX overlap: 61% of top holdings shared

Bottom line

How much do PHSYX and PRHSX overlap?

61% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 60.3% of PHSYX's assets and 51.4% of PRHSX's. They share a meaningful core but differ in the rest of the portfolio.

PRHSX holds far more positions (279 vs 115), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

PHSYXPRHSX
Weight overlap (top 25)61%
Shared holdings13
Weight in shared holdings60.3%51.4%
Total positions115279
Expense ratio0.79%0.83%
Holdings as ofMay 31, 2026Jun 30, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Holdings PHSYX and PRHSX have in common

Holding% of PHSYX% of PRHSXOverlap
Eli Lilly & Co.13.15%14.28%13.15%
Johnson & Johnson8.46%6.63%6.63%
UnitedHealth Group, Inc.6.93%5.99%5.99%
AbbVie, Inc.6.05%5.10%5.10%
Merck & Co., Inc.4.88%4.01%4.01%
Thermo Fisher Scientific, Inc.4.50%2.52%2.52%
Intuitive Surgical, Inc.4.04%1.87%1.87%
CVS Health Corp.2.74%0.94%0.94%
Gilead Sciences, Inc.2.63%2.82%2.63%
Cardinal Health, Inc.2.12%1.03%1.03%
Vertex Pharmaceuticals, Inc.1.97%2.28%1.97%
Bristol-Myers Squibb Co.1.75%2.11%1.75%
Amgen, Inc.1.11%1.82%1.11%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in PHSYX

  1. Novartis AG — 5.13%
  2. AstraZeneca plc — 4.67%
  3. Sanofi SA — 3.23%
  4. Edwards Lifesciences Corp. — 2.80%
  5. Roche Holding AG — 2.79%
  6. McKesson Corp. — 2.14%
  7. Novo Nordisk A/S — 1.90%
  8. Boston Scientific Corp. — 1.80%
  9. Dexcom, Inc. — 1.64%
  10. Hoya Corp. — 1.52%
  11. Putnam Short Term Investment Fund — 1.35%
  12. HCA Healthcare, Inc. — 1.18%

Only in PRHSX

  1. Abbott Laboratories — 1.89%
  2. Stryker Corp — 1.78%
  3. Elevance Health Inc — 1.53%
  4. Natera Inc — 1.44%
  5. Danaher Corp — 1.43%
  6. Guardant Health Inc — 1.23%
  7. Royalty Pharma Plc- Cl A — 0.97%
  8. Tenet Healthcare Corp — 0.94%
  9. Kymera Therapeutics Inc — 0.89%
  10. Protagonist Therapeutics Inc — 0.85%
  11. Moderna Therapeutics Inc — 0.83%
  12. Brightspring Health Services — 0.82%

Asset mix

Asset typePHSYXPRHSX
Stocks98.2%96.4%
Preferred stock—3.0%
Other1.4%—
Cash & short-term funds0.6%0.7%
Bonds—0.2%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Country mix

CountryPHSYXPRHSX
US76.2%92.6%
CH7.9%0.5%
GB6.4%1.7%
FR3.2%0.2%
DK2.4%0.7%
JP2.4%0.5%
NL1.2%1.0%
IE—0.8%

Source: SEC Form N-PORT (periods May 31, 2026 / Jun 30, 2026)

Check another pair

FAQ

How much do PHSYX and PRHSX overlap?
About 61% by weight. 13 securities appear in both funds' top 25 holdings; they make up 60.3% of PHSYX's assets and 51.4% of PRHSX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do PHSYX and PRHSX have in common?
The largest shared holdings are Eli Lilly & Co., Johnson & Johnson, UnitedHealth Group, Inc., AbbVie, Inc., Merck & Co., Inc..
Should I own both PHSYX and PRHSX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, PHSYX or PRHSX?
PRHSX is broader, with 279 positions versus 115 for PHSYX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.